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Abstract
Background: About 35 % of non-elderly U.S. adult Medicaid enrollees have a behavioral health condition,
such as anxiety, mood disorders, substance use disorders, and/or serious mental illness. Individuals with serious
mental illness, in particular, have mortality rates that are 2 to 3 times higher as the general population, which
are due to multiple factors including inactivity, poor nutrition, and tobacco use. 61 % of Medicaid beneficiaries
with behavioral health conditions also have multiple other co-occurring chronic physical health conditions,
which further contributes to morbidity and mortality. The Wellness Incentives and Navigation (WIN) project
is one of 10 projects under the Centers for Medicare and Medicaid Services “Medicaid Incentives for the
Prevention of Chronic Diseases” Initiative, to “test the effectiveness of providing incentives directly to Medicaid
beneficiaries of all ages who participate in prevention programs, and change their health risks and outcomes
by adopting healthy behaviors.”
Methods/Design: WIN is a three-year randomized pragmatic clinical trial designed to examine the comparative
effectiveness of the combined use of personal navigators, motivational interviewing, and a flexible wellness account
on cardiovascular risk reduction among individuals in Medicaid with co-occurring physical and mental health
conditions or serious mental illness alone relative to the usual care provided within Medicaid Managed Care.
1250 individuals, identified through Medicaid claims data, were recruited and randomly assigned to an intervention
group or control group with outcomes tracked annually. A comparison group was also recruited to help assess the
study’s internal validity.
Discussion: The primary outcomes are physical and mental health related quality-of-life as measured by the SF-12, and
BMI, blood pressure, LDL-C, and Hba1c results for those who are diabetic measured clinically. The purpose of this paper
is to present the unique design of the WIN trial prior to results becoming available in hopes of assisting other researchers
in conducting community-based randomized pragmatic trials. Outcomes will be assessed through the linkage of patient
reported outcomes, health care claims, and electronic health record data.
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Background
Medicaid is the largest source of health care financing
for individuals with behavioral health conditions. About
35 % of all non-elderly U.S. adult Medicaid enrollees
have a behavioral health condition, such as anxiety,
mood disorders, substance use disorders (SUD), and/or
serious mental illness (SMI). SMI includes conditions
such as schizophrenia, bipolar disorder, and major
depressive episodes. Among those Medicaid beneficiaries
with behavioral health conditions, 61 % also have a co-
occurring chronic physical health condition, the majority
of which include cardiovascular disease (CVD) and con-
ditions linked to increased CVD morbidity and mortal-
ity, such as diabetes and chronic obstructive pulmonary
disorder [1]. Individuals with SMI, in particular, are two
to three times as likely to die from CVD as adults relative
to the general population [2]. This high CVD prevalence
and excess mortality, which contributes to increased
health care use and expenditures, is often attributable to
an increased occurrence of modifiable risk behaviors
including inactivity, poor nutrition, and tobacco use [1, 3].
While some behavioral interventions yield moderately
positive findings in terms of weight reduction and im-
proved health related quality of life (HRQOL), significant
gaps in knowledge remain about effective CVD risk reduc-
tion strategies among individuals with behavioral health
conditions in general and those enrolled in Medicaid
specifically [3].
For example, few CVD risk reduction studies include
individuals with co-occurring physical and behavioral
health conditions, especially those who have serious
mental illness (SMI), despite their high risk for cardio-
vascular disease [3]. Moreover, most studies do not
conduct multi-year follow-up of participant outcomes,
limiting the available knowledge about long-term effects
of behavioral interventions on CVD risk reduction [4, 5].
Finally, many CVD risk reduction studies are not em-
bedded in real-world settings where individuals routinely
receive their health care, limiting generalizability of the
study findings.
We sought to address limitations of prior CVD risk
reduction studies through the implementation and
evaluation of the Wellness Incentive and Navigation
(WIN) project. The WIN Project is one of 10 national
demonstration projects funded across different states
under the Centers for Medicare and Medicaid Services
“Medicaid Incentives for the Prevention of Chronic
Diseases (MIPCD)” Initiative. The goal of the initiative is
to “test the effectiveness of providing incentives directly
to Medicaid beneficiaries of all ages who participate in
MIPCD prevention programs, and change their health
risks and outcomes by adopting healthy behaviors” [6].
The WIN project is a three-year longitudinal random-
ized pragmatic clinical trial designed to examine the
comparative effectiveness of the combined use of per-
sonal navigators, motivational interviewing (MI), and a
flexible wellness expense account on CVD risk reduction
among individuals in Medicaid with (1) co-occurring
physical and mental health conditions or (2) SMI alone,
relative to usual care provided within Medicaid Managed
Care. The WIN intervention consists of (1) personal
navigators housed within Medicaid managed care plans
who work with participants to develop and refine health
promotion goals and strategies using MI techniques; and
(2) a person-directed flexible wellness expense account
that provides participants with the financial infrastruc-
ture to purchase supplies and services to implement
their wellness strategies (e.g. gym memberships; bicy-
cles). The WIN Project is unique among the 10 state
projects in its focus on individuals with co-occurring
physical and behavioral health conditions, including
SMI, its implementation through Medicaid Managed
Care plans, the development of individualized person-
centered goals, and the use of person-directed flexible
wellness accounts. The person-centered goals were con-
strained to wellness behavior including improved nutri-
tion and exercise to promote weight loss, tobacco
cessation, and stress reduction, all known risk factors for
CVD [3].
The purpose of this paper is to describe the WIN
project in detail including the study’s (1) conceptual
framework, (2) design, (3) participant recruitment, and
(4) pragmatic focus.
Conceptual framework
The WIN project combines three specific strategies,
each of which has demonstrated effectiveness in facilitat-
ing health promotion activities to reduce CVD risk: per-
sonal navigators, motivational interviewing (MI), and
consumer-directed wellness accounts, among healthy in-
dividuals and those with chronic conditions. However, to
our knowledge, the effectiveness of these interventions
has not been tested, in combination, with individuals
with co-occurring physical and behavioral health condi-
tions, including SMI. Our focus in the use of these strat-
egies is rooted in the concept of patient activation
(Fig. 1). Patient activation is defined as: “understanding
one’s own role in the care process and having the know-
ledge, skills, and confidence to take on that role”. Patients
who are more activated, as measured by the Patient Acti-
vation Measure (PAM) [7], engage in more positive health
behaviors including: disease self-management [8], better
diet and exercise [9], preventive care, and seeking and
using health information [10].
In our conceptual framework, we hypothesize that
patient activation mediates the effects of the combined
intervention components to: (1) increase participant
health related quality of life (HRQOL), (2) improve the
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clinical measures of body mass index (BMI), blood
pressure (BP), Low Density Lipoprotein- Cholesterol
(LDL-C), and Hemoglobin a1c (Hba1c), and (3) reduce
health care use and expenditures (total, inpatient, out-
patient, emergency department, and pharmacy). In our
conceptual framework, we also incorporate six categor-
ies of control variables that may influence an individ-
ual’s capacity to take an active role in managing their
health and experience increased patient activation
(participant age, gender, race/ethnicity, census tract
poverty, cognitive functioning, and health status) [11].
We hypothesize that these control variables will have
an influence on patient activation and also exert a
direct effect on the outcomes of interest.
Health coaches called personal navigators have been
shown to increase patient activation and contribute to a
range of health outcomes including improved blood
pressure and lipoprotein levels and reduced emergency
department visits and hospitalizations [7]. MI is a
person-centered counseling approach used to help indi-
viduals explore and resolve their ambivalence around
behavior change in favor of positive behavioral changes
[12]. The MI approach initially demonstrated efficacy in
treating individuals with substance use disorders (SUDs).
MI-based health coaching also has been shown to
increase activation levels and perceived overall health
status among individuals with chronic conditions, such
as diabetes, heart failure, chronic obstructive pulmonary
disease (COPD), and mental illness. Individuals with
chronic conditions receiving MI-based health coaching
demonstrate increased readiness to make lifestyle
changes related to drug, alcohol and tobacco use,
physical activity, stress management, weight manage-
ment and sleep [13, 14].
Medicaid recipients often do not have the financial
resources to take action on their own initiative to make
nutrition, exercise, and lifestyle changes to improve their
own health. There is a small, but growing, body of evi-
dence about the use of financial resources to help indi-
viduals make lifestyle changes to improve their health.
Typical financial intervention studies involve rewarding
participants with a financial incentive for achieving
health goals, such as smoking cessation and weight loss.
Funds are not usually provided to support the purchase
of items or services to help the participant achieve his or
her goals. Financial incentives have some demonstrated
effectiveness in helping participants achieve their goals
compared with control groups not receiving incentives,
although the outcomes are mixed and tend to be short
term [15–21].
In contrast to traditional financial incentive models,
consumer-directed approaches provide participants with
the autonomy and the funds to direct portions of their
own care and to purchase health services that are mean-
ingful to them. Consumer-directed efforts are considered
particularly important for individuals with chronic con-
ditions to better support them in managing their chronic
conditions within the context of their functional status
and living conditions [22, 23]. Contextual characteristics
may support or constrain an individual’s ability to
increase their activation and play a more active role in
their health and health care. Access to financial re-
sources influences an individual’s ability to acquire the
skills to improve their health and may have an effect on
the levels of patient activation [10]. While the effects of
providing financial resources to increase patient activa-
tion have not been specifically tested, to our know-
ledge, increasing financial resources allows participants
Fig. 1 WIN Conceptual Frameworks
Shenkman et al. BMC Health Services Research  (2015) 15:579 Page 3 of 13
to purchase items that will enhance their ability to
manage their health.
For the WIN Project, the use of personal navigators,
MI, and flexible funds were integrated to form the inter-
vention. The purpose of the intervention is to foster the
achievement of health goals in a Medicaid population
with co-occurring physical and mental health conditions
or SMI through increasing patient activation. Cross-
sectional analyses of adult patients seen in a large health
system have shown that for every additional 10 points in
patient activation, using the Patient Activation Measure
(PAM), the predicted probability of having an ED visit,
being obese, or smoking decreased by one percentage
point. Further, the likelihood of having clinical indicators
in the normal range (Hba1c and LDL-C) was one per-
centage point higher [9]. It is not known whether these
same changes will be observed in a population with co-
occurring physical and mental health conditions.
For the WIN intervention, personal navigators use MI
to collaborate with the participants to address the dis-
crepancy between their current and desired health
behaviors. The WIN personal navigators then support
autonomous choice by helping the participants identify
strategies or options that can be used to resolve those
discrepancies [24]. The participants are given a flexible
wellness account of up to $1150 annually for up to three
years to purchase services and supports to implement
the strategies they identified to meet their health goals.
Contextual variables also influence patient activation
including socio-demographic and health characteristics
[11]. The relationship between cognitive functioning and
patient activation is not known. However, issues related
to cognitive functioning may have a significant effect on
capacity to engage with personal navigators, establish
and meet goals, and manage a flexible wellness account
[25]. Deficits in executive functioning, in particular,
which includes planning, organizing, strategizing, paying
attention to and remembering details, and managing
time, have been linked to poor health outcomes and
inadequate self-care [26, 27].
Age, gender, race/ethnicity, and health status are asso-
ciated with worse health outcomes. For example, older
adults and racial/ethnic minorities are more likely to re-
port poorer health status and to have hypertension,
obesity, high cholesterol, and poor Hba1c control than
younger, non-minority individuals [28–31]. They also are
more likely to have potentially preventable emergency
department visits and hospitalizations [30, 32–34]. Fur-
ther, individuals residing in census tracts with high per-
centages of families residing below 100 % of the federal
poverty level (FPL) are more likely to experience adverse
health outcomes [34, 35].
In keeping with a person-centered approach, our primary
study outcomes are participant self-reported physical and
mental HRQOL; and changes in clinical measures that are
associated with cardiovascular health including: BMI, BP,
and total cholesterol (LDL-C) results as well as Hba1c
results for those who are diabetic. We hypothesize, consist-
ent with the findings of other studies, that participants will
have improved HRQOL and clinical measures.
Secondarily, we are examining whether patient activa-
tion is a mediator related to changes in inpatient, emer-
gency department (ED), outpatient, pharmacy and total
health care expenditures for the WIN participants. We
hypothesize that total health care expenditures will be
reduced because the participants have higher patient
activation and greater capacity to manage their health.
Expenditures also will be examined relative to the cost
of running the WIN Program, providing estimates of the
cost-effectiveness of the program. While our analysis is
not specific to expenditures associated with CVD, a
broad expenditure analysis will provide important infor-




This study is a longitudinal randomized pragmatic clin-
ical trial (PCTs) with randomization at the individual
Medicaid enrollee level. Individuals were randomized to
an intervention group to receive the combined interven-
tion components of (1) personal navigators profession-
ally trained in motivational interviewing and (2) flexible
wellness accounts or to a control group receiving the
usual care provided within Medicaid managed care. The
study recruitment procedures are described more fully
under Recruitment Strategies.
All members meeting the WIN criteria eligibility
criteria were randomly assigned to the intervention or
control group prior to seeking consent to participate.
This technique, known as a Zelen design, is utilized in
research trials in which there is a large difference in ser-
vices provided to the treatment group relative to the
control group [36]. This design technique eliminates the
disappointment of the control group in not receiving the
benefits provided to the treatment group, thereby redu-
cing resentful demoralization and attrition and improv-
ing internal validity of the design. Following the Zelen
design concept, after the individual is randomized, the
potential participant is contacted and only receives an
explanation of the intervention that he or she will
receive for the arm in which he or she was assigned. The
study recruitment procedures are described more fully
under Recruitment Strategies.
Study setting
The three Medicaid Managed Care Plans participating in
the Texas STAR + PLUS Program in Houston, Texas
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were invited to participate – Amerigroup, United-
Health Care, and Molina Health Plan. The STAR +
PLUS Program began in 1997 in Houston as a 1915(b)/
(c) waiver program for individuals in Medicaid with
disabilities severe enough to qualify for supplemental
security income. Program waivers authorized by sec-
tions 1915(b) and 1915(c) of the Social Security Act
are “intended to control costs, while allowing states
administrative flexibility to operate their programs”
[37]. Section 1915(b) waivers permit states to waive
the freedom of choice provision so that eligible benefi-
ciaries receive health care services from a limited set
of providers; typically within a managed care network
model. Section 1915(c) authorizes states to provide
home- and community- based services (HCBS) to indi-
viduals who might otherwise require care in an institu-
tional setting such as a nursing home. HCBS can
include personal attendant services, homemaker ser-
vices, case management, environmental modifications,
and respite care.
Overall, the primary focus of the STAR + PLUS Pro-
gram is to improve the quality of care for enrollees
with disabilities through coordinated and comprehen-
sive care. The program delivers acute and long-term
services through a single system, employs service co-
ordinators who develop individual care plans and as-
sist enrollees in receiving health care services, and
emphasizes HCBS as alternatives to institutional care
[38]. As of 2014, STAR + PLUS is offered throughout
Texas. The Harris service delivery area (SDA) was se-
lected for the WIN Project because Harris County was
the site where the STAR + PLUS Program began. Two
of the three Harris SDA plans have been involved
since the inception of STAR + PLUS. The managed
care plans’ longevity and experience with the program
in the Harris SDA provided sufficient infrastructure
and stability to launch a pragmatic clinical trial, with
personal navigators hired within each of the managed
care plans.
A comparison group, not receiving the intervention,
was also recruited to assess the external validity of the
study. The comparison group of STAR + PLUS enrol-
lees reside in two adjacent communities: Corpus
Christi, San Antonio and the immediate surrounding
counties, which comprise the Nueces and Bexar SDAs
and otherwise have the same criteria for WIN eligibility
as the intervention and control groups. The individuals
were randomly selected from among the managed care
plans participating in STAR + PLUS in those areas;
which were the same managed care plans participating
in the WIN Study in Houston. The comparison group
will provide enhanced information about whether any
changes in the outcomes are attributable to the effects
of the intervention.
WIN as a pragmatic clinical trial
In designing WIN as a pragmatic clinical trial, the re-
search team used the Pragmatic-Explanatory Indicator
Summary (PRECIS) instrument, which is an instrument
designed to assist researchers in clarifying and refining
the study along a pragmatic-exploratory continuum [39].
PCTs are designed to estimate the effectiveness of inter-
ventions under usual, real-world conditions in health
care applications [40]. In contrast, efficacy or explana-
tory studies examine interventions under ideal clinical
conditions. The PRECIS instrument was developed
because “very few trials are purely pragmatic or explana-
tory” but rather vary along a continuum within key
domains [41]. Table 1 describes how the WIN project
fits within the 10 domains of the PRECIS instrument.
The WIN project varies along the pragmatic-
explanatory continuum in each of the domains. Ultim-
ately, the WIN research team characterized the study as
a PCT because of the following key characteristics: (1)
the personal navigators are embedded within Medicaid
managed care plans, which are the usual source of care
for individuals meeting the study eligibility criteria; (2)
the personal navigators are monitored in conducting the
intervention but the person-centered nature of the inter-
vention leads to adaptability to individual needs; (3)
participants are monitored for their adherence to the
wellness strategies they selected through in-person meet-
ings and teleconferences with the navigators, but they
have flexibility in choosing their wellness goals and strat-
egies; and (4) the Medicaid managed care plans provide
care to the control group according to contractual obli-
gations with the State of Texas Medicaid Program but
also according to their own internal standards, which
can vary among the plans.
Participants
Inclusion criteria
STAR + PLUS enrollees in Amerigroup, United, or
Molina Health Plans, age 21–55, in the Harris SDA in
Texas were eligible to participate. Diagnostic inclusion
criteria consisted of: (1) serious mental illness (SMI)
diagnosis (e.g. schizophrenia, bi-polar disorder, major
depressive disorder) alone; (2) behavioral health diagno-
ses (e.g., anxiety, depression, substance use disorder)
coupled with a chronic physical health diagnosis (e.g.
diabetes, COPD); or (3) all three categories – SMI,
behavioral health diagnosis and a chronic physical health
condition. Table 2 shows the diagnostic criteria for
classification of SMI, behavioral health conditions, and
physical health chronic conditions.
Exclusion criteria
Individuals were excluded if they were dually eligible for
Medicare and Medicaid or if they had intellectual or
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Table 1 The WIN Project Design using the PRECIS Domains
Domain WIN Design
Eligibility criteria for participants Trial enrollment limited to individuals with co-occurring physical and behavioral health
conditions and/or SMI, and current enrollment in the Texas Medicaid STAR + PLUS
Program in the Harris Service Delivery Area. The strict enrollment criteria used are
typically seen in explanatory trials.
Extent of flexibility in application of the intervention The combination of personal navigators, use of MI, and the $1150 annual flexible
wellness account is prescribed and must be followed. However, the self-directed
nature of the intervention components reflects a participant-centered, tailored
intervention. The intervention is pragmatic in that the navigators were embedded
in Medicaid managed care plans were health care is normally delivered and the
health and wellness goals and strategies were developed based on participant
preferences.
Degree of personal navigator expertise in applying and
monitoring the intervention
All personal navigators underwent an initial 1.5-day MI training by a psychologist
who is an expert in MI. Following this training, navigators participated in 5 weeks
of constructive phone calls addressing specific taped interactions. The personal
navigators also undergo annual MI refresher training. An expert psychologist also
monitors 2 randomly selected appointments using the Motivational Interviewing
Treatment Integrity (MITI) coding scheme to assess navigator competency and
adherence to MI on 6 dimensions (Global Rating, Giving Information, Questions,
Simple Reflections, Complex Reflections, Spirit). The psychologist then provides
feedback and refresher information to the personal navigators if their scores fall
below minimal requirements for competency. The navigators adapt their approach
to their participants’ needs but are required to follow MI techniques. This
component of WIN has both pragmatic and explanatory elements.
Extent of flexibility in application of standard care for the
control group
The standard care provided to the control group represents the usual care
provided through the Medicaid Managed Care Plans. The State has contractual
requirements for the Medicaid Managed Care Plans but the Plans have latitude in
how they meet those requirements. This component of WIN is pragmatic.
Degree of practitioner expertise in applying and monitoring the
application of standard care for the control group
Each Medicaid Managed Care Plan has a provider network and the providers must
meet a set of licensure and state standards to be part of the network. However, the
practitioners likely vary widely in how care is delivered to the Medicaid enrollees.
This component of WIN is pragmatic.
Intensity of follow-up of trial participants Trial participants are monitored closely through continued contact with study
personnel. Intervention participants are contacted monthly by navigators and if not
successfully contacted, a number of retention efforts are planned to re-engage this
member back into the trial. Control and comparison participants are contacted
monthly by mail and phone to provide updated contact information. This component
of WIN is explanatory.
Nature of the primary outcomes The primary outcomes are participant reported physical and mental health related
quality of life using the SF12, which is measured in a standardized format; and
clinical variables including blood pressure; HDL, LDL-C, Hba1c results for those who
are diabetic; and BMI, which are obtained from the participants’ medical records. In
addition, inpatient, emergency department, outpatient and total health care expenditures
are obtained from the Medicaid claims and encounter data. The primary outcome is
collected using methods consistent with an explanatory trial. The medical record and
health care expenditure results are pragmatic in that the information is gathered for
purposes other than the WIN Project.
Participant protocol compliance The participants meet in-person with their personal navigators once every three
months and have monthly teleconference calls where wellness goals and strategies
are reviewed and discussed. Participants who have not completed appointments
are contacted in a number of ways to ensure continued and timely completion.
The participants are monitored monthly in terms of the spending on their flexible
wellness accounts. Participants who are not using their flexible wellness accounts
as planned receive additional support from the personal navigator in purchasing
items to support their wellness goals. This component of WIN is explanatory.
Navigator protocol compliance In addition to the monthly monitoring of MI-adherence, navigators are closely
monitored for the number of participants successfully completing appointments
each month. Navigators falling below recommended study standards are further
consulted to discuss barriers for success. This component of WIN is explanatory.
Specification and scope of analysis of primary outcomes The analysis plan was pre-specified and models follow an intent-to-treat structure
to alleviate the bias in randomization of participants.
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cognitive diagnoses indicative of severe cognitive impair-
ment including: 290.X (dementia) and 318–319 (moder-
ate to severe mental retardation). These individuals were
excluded because of concerns that they could not pro-
vide informed consent or adequately participate the
intervention. The participants were identified using
Medicaid enrollment files and health care claims data
from Calendar Year 2011, provided through a data use
agreement with the Texas Health and Human Services
Commission.
Recruitment procedures
Individuals meeting the inclusion and exclusion criteria
were randomly selected from the STAR + PLUS Harris
SDA enrollment files to contact about potential study
participation. The targeted number of intervention par-
ticipants varied by the size of the managed care plan.
Amerigroup and United HealthCare had similar STAR +
PLUS enrollment sizes and Molina had the smallest.
Therefore, the final targeted number of WIN Study par-
ticipants per health plan was 500 each for Amerigroup
and United HealthCare and 250 for Molina.
Consistent with the Zelen Design, individuals were
assigned to either the intervention or control group
prior to making contact with the individuals. Both
groups were told that the WIN study was focused on
understanding the best ways to help individuals with
physical and mental health conditions and/or SMI
develop and meet health and wellness goals that may
improve their health outcomes including blood pressure
and cholesterol control. Those randomly assigned to the
intervention group received an explanation of the inter-
vention strategies and information about baseline and
annual telephone surveys. Those in the control and
comparison group were told that they would participate
in baseline and annual telephone surveys.
The primary recruitment method involved mailing an
introductory letter customized to the individual’s group
assignment and the recruitment brochure followed by
telephone outreach within 7 to 10 days of mailing the
letter. Participants were recruited in waves from May
2012 through July 2013 with the National Opinion
Research Center (NORC) conducting the outreach calls.
Recruitment progress was monitored through weekly
calls with NORC with the goal of enrolling 40 total
participants per week across the two larger plans and 20
participants per week in the smaller health plan.
For those individuals who were not able to be con-
tacted via letter or phone, research assistants were
provided a list of participant names and addresses and
went door-to-door providing the introductory letter and
brochure with the goal of obtaining updated contact
information and/or consent to participate in the study.
N = 150 door-to-door outreach attempts were made,
yielding 11 participants. Due to the low yield, the door-
to-door outreach was discontinued after 1 month and
ongoing effort was placed on the telephone contact.
For the intervention and control groups, 12,349 indi-
viduals were initially identified as meeting the WIN eli-
gibility criteria in the Harris SDA and 9,044 randomly
selected names from that group were sent to NORC for
attempted contact; 2888 were successfully contacted;
and 1259 agreed to participate in the study (Fig. 2).
Analyses comparing those who agreed to be in either
the control or the intervention group relative to those
who could not be located or refused revealed no
significant differences in race/ethnicity, or diagnostic
category, though more females than males chose to par-
ticipate (p < .001).
Intervention
Personal navigators
A total of ten personal navigators were hired across the
three plans – four each for Amerigroup and United
HealthCare and two for Molina. Each personal navigator
has a caseload of approximately 70 participants. The
intervention was designed to allow for two in-person
meetings, held one month apart, in the participant’s
home. Following these initial meetings, the participant
receives two monthly telephone calls and a quarterly in-
Table 2 Diagnostic Criteria for Participation in the WIN Study
Variable Name Diagnostic Criteria
Physical Health Condition
(PHC)
One or more of the following ICD-9 codes present in any field (e.g., primary, secondary)Asthma 493. xx; Cerebrovascular
Disease 430.xx-438.xx; Intracranial Injury (excluding skull fracture) 851.xx-854.xx; Chronic Obstructive Pulmonary Disease
and Allied Conditions 490.xx-496.xx; Neoplasms 140–239; Diabetes 250.xx; Heart Failure 428.xx; HIV/AIDS 042, V08,
079.53, 795.71; Hereditary and Degenerative Diseases of the Central Nervous System 330.xx-337.xx; Other Disorders of
the Central Nervous System 340.xx-349.xx; Disorders of the Peripheral Nervous System 350.xx-359.xx; Rheumatoid
Arthritis and Other Inflammatory Polyarthropathies 714.xx; and Hepatitis (alcoholic 571.1; history of hepatitis C v12.09;
hepatitis type C 070.51, 070.54, 070.70.
Serious Mental Illness (SMI) One or more of the following ICD-9 codes present in any field (e.g., primary, secondary) – measuring serious mental




Neurotic Disorders, Personality Disorders, and Other Non-Psychotic Mental Disorders (Includes alcohol and drug
dependence syndromes) (300.xx-316.xx).
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person meeting. The caseload size was selected to
balance the estimated amount of time each navigator
would spend on each intervention group participant
during a 40 hour work week along with cost consider-
ations related to the number of navigators that could be
funded through the project. Approximately 1 hour is al-
located for each intervention participant per month to
review and discuss goals, progress toward those goals,
and the identification of wellness strategies and associ-
ated purchases using the flexible wellness account. An
additional hour was provided to account for travel to the
participants’ homes, contact with the participant and
other documentation paperwork.
Motivational interviewing
The personal navigators use MI techniques when work-
ing with the intervention participants. The MI training
and ongoing monitoring of the navigators’ MI tech-
niques is described in Table 1. Using MI techniques, the
Navigators work with the participants to identify their
health risks and to understand their motivations for
change. Emphasis is placed on identifying health risks,
which participants were either acknowledging as an issue
or already taking steps to change.
Flexible wellness accounts
Once the participant has identified strategies to meet
his/her wellness goals, the participant and navigator dis-
cuss and select items to purchase. For example, a
participant has identified obesity as a health risk, 20-
pound weight loss as a goal, and stress reduction and in-
creased physical activity in the form of walking to meet
those goals. The navigator then works with the partici-
pant to identify services and/or items needed to meet
these goals, such as books or recordings on mindfulness
and stress reduction, walking shoes, and yoga classes.
The necessary funds to purchase the items and services
are placed on the participant’s debit card. Funds are
added to the debit card as needed to purchase agreed
upon items and services up to a maximum of $1150 an-
nually for each of three years.
The debit card system is novel because participants are
given financial support to meet their health goals. In trad-
itional wellness programs, participants receive a financial
incentive for completing a health goal or action (e.g. given
$20 for losing 20 pounds). Traditional approaches may be
constrained in their success among low-income popula-
tions that do not possess the financial means to purchase
items for wellness. The navigators provide training to the
participant in debit card use. In addition, participants sign
agreements acknowledging that debit card funds may only
be used for agreed upon purchases and that they are
restricted from purchasing certain items (e.g., items/
services covered by their health plan, vitamins, e-cigarettes).
Participants are asked to provide receipts to their navigators
at each in-person visit. The participants’ agree to allow the
transactions to be monitored through the Bank of America,
which provides the debit cards.
Fig.2 Sample selection procedures
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Visit schedule – intervention group
The intervention group visits are organized into three
types: Intake, Wellness, and Annual Review. One in-
home intake visit was held where the participant: 1)
completes a health risk assessment tool, 2) discusses
health risks identified from the tool, 3) develops goals to
address selected risks, and 4) identifies strategies to meet
those goals. The wellness visits consist of monthly phone
calls and a quarterly in-home visit. During the wellness
visits, the navigator reviews the participants’: health
risks, goals, and strategies; self-reported outcomes in
meeting the goals; wellness purchases made to address
the goals; and self-reported satisfaction with strategies to
reduce health risks and purchases made; and requests
for new strategies and purchases to meet health goals.
During the annual review visits, participants complete a
new health risk assessment, review current progress and
goals, and determine whether they wish to add or
remove selected health risks, goals and strategies.
Control and comparison group interactions
The control and comparison groups complete the health
risk assessment at baseline and annually. The control
group is contacted on a monthly basis and the compari-
son group on a quarterly basis via mailings requesting
current contact information. Monetary compensation is
provided for completing the baseline and annual surveys
and for maintaining monthly or quarterly contact. Due
to the high transitive nature of this population, this
strategy ensures retention of a high-risk population.
Measures
The first primary outcome measure is self-reported
physical and mental HRQOL using the Short Form-12
(SF-12). The SF-12 has been validated across a number
of chronic diseases and conditions [42]. The survey con-
sists of 12 questions measuring functional health and
well-being. Participants answer questions related to daily
functioning, difficulties in physical tasks, and disruptions
in life due to mental illness (e.g. depression, anxiety).
The overall score can be further classified into two sum-
mary scores for physical and mental health. We also are
examining whether there are changes in the following
clinical measures: 1) blood pressure, 2) BMI, 3) choles-
terol (LDL-c), and 4) Hba1c (only for participants with
diabetes). Secondary outcome measures are: health care
expenditures reported as total, inpatient, outpatient and
emergency department expenditures.
Participant reported HRQOL is assessed at baseline and
annually for each of the three study years after entry. All
other primary and secondary outcomes are assessed for
two years prior to the participants’ entry into the WIN
study and annually for each of three years thereafter. The
clinical data are recorded from all outpatient encounters
in the electronic and paper health record for the baseline
year and for each of the subsequent three years. The
expenditure data are obtained from the Medicaid health
care claims data.
Health status, sociodemographic, and cognitive infor-
mation are also collected. Health status is measured
using the 3 M Clinical Risk Groups (CRGs), which uses
ICD-9-CM diagnosis codes from health care claims to
assign participants to hierarchically defined health status
groups [43]. Participants are classified into the follow-
ing health status categories: minor chronic conditions
(e.g., asthma), moderate chronic conditions (e.g., dia-
betes), or major chronic conditions (e.g., cancer).
Sociodemographic control variables included age
(in years), gender, and race/ethnicity (non-Hispanic
white, non-Hispanic black, Hispanic, other). Context-
ual geographic variables included the percentage of
the population living in poverty in the participants’
census tracts.
Another variable that may play an important but un-
derappreciated role is cognitive ability, which is strongly
related to clinical symptoms and overall functioning
[44]. Patients’ educational level is often applied as a
proxy for cognitive ability. However, education may not
reflect current capacity though it may reflect prior
achievement. This dissonance may be particularly evi-
dent in chronically ill populations such as those partici-
pating in the WIN study, for which medications,
uncontrolled disease, and life stressors may adversely
affect brain integrity and cognitive abilities [45–47].
Thus, accounting for cognitive capacity may be a critical
control variable when examining intervention outcomes.
A cognitive battery previously developed by Wilson
and colleagues (2005, 2010) was used to gather informa-
tion about the participants. This battery was developed
to examine key components of executive function, spe-
cifically attention, semantic organization and working
memory. These processes are interrelated and are com-
monly presumed to underlie the effective conduct of
daily life requirements. The individual tests are briefly
described below and administered following approaches
used in previous work [48, 49].
To assess the ability to encode novel logically-related
information, participants listened to a tape of the “Anna”
story taken from the Wechsler Memory Scale [50].
Immediately following the tape, participants are asked to
recall as much of the story as possible. Standard admin-
istration and scoring guidelines are used.
To assess attention and working memory, participants
complete three digit span tasks. In the forward and
backward digit span tests, interviewers read sets of digits
(of increasing lengths) at a set pace of 1/sec. Set length
increases to 8 (forward) or 7 (backward) digits or until
participants respond incorrectly to two sets of the same
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length. Participants are required to repeat the digits in
the order presented (forward) or to invert the order
(backward). In the digit ordering test, interviewers read
a list of digits which may include repeated numbers.
Participants are required to recall the digits in their
appropriate numerical sequence and to recall duplicates
of a number. For example, if the interviewer read “4, 2,
8, 2, correct recall would be reflected in the response “2,
2, 4, 8”. Set length increases to 9 digits or until partici-
pants respond incorrectly to two sets of the same length.
The ability to manipulate information in existing
semantic networks was assessed with two fluency tests.
The first test requires participants to recall as many ani-
mals as possible in one minute, the second, vegetables.
Proper nouns and repeated items are scored as incorrect.
Fantasy animals (e.g., unicorns) are also disregarded.
Certain fruits commonly classified as vegetables, such as
tomatoes were accepted.
Data sources
This study requires linking health care claims data with
person-reported outcomes, executive functioning re-
sults, and electronic or paper health record data.
Person-level administrative enrollment and claims data
provided by Texas Health and Human Services Com-
mission is being used to obtain the participants’ age,
sex, race/ethnicity, and census tract of residence. En-
rollment records are linked to claims data that includes
International Classification of Diseases (ICD-9-CM)
diagnosis codes, Current Procedural Terminology (CPT)
codes, charges, National Drug Codes (NDC), rendering
provider, billing provider, and dollar amount of claim
paid to the provider, The rendering provider informa-
tion is used to identify the participants’ primary care
providers to obtain electronic health records. Electronic
and paper health records are used to abstract the clin-
ical data (e.g., blood pressure, BMI, LDL-c, and Hba1c).
These data will be supplemented with county-, Zip
Code Tabulation Area- and census tract- level data
from the U.S. Census Bureau, and U.S. Department of
Commerce in order to capture important geographic
contextual factors.
Ethical considerations
The University of Florida Health Science Center Institu-
tional Review Board (IRB-01) reviewed and approved all
study materials including the study protocol, informed
consent document, recruitment materials, and assess-
ment instruments. Informed consent documents were
obtained electronically from intervention participants
and verbally from the control and comparison partici-
pants. The trial was registered with ClinicalTrials.gov.
Sample size
We performed the power analysis based on the hypothesis
test of whether there is a significant treatment by time
interaction in the analysis of repeated measurements of
the primary outcome of SF-12 scores. The SF-12 scores
are measured a total of four times during the study period:
baseline, year 1, year 2, and year 3. In order to align the
power analysis with the primary data analysis [51], we
computed statistical power based on a longitudinal model
with SF-12 from study years 1 through 3 as responses and
the baseline (year 0) measure as a covariate.
We estimated that the mean and standard deviation of
the SF-12 to be 50 and 10, respectively [52]. Based on
reports in the SF-12 manual and previous publications
that used the SF-12, we estimated the reliability of the
scale to be 0.70 across one year. For the test-retest
correlation matrix, we assumed that it followed a
generalization of an autocorrelation (AR) form called a
LEAR model [53]. The LEAR model allows greater flexi-
bility when modeling correlation decay across time.
Finally, we used the Bonferroni correction to control the
Type I error rate, which was set at 0.01 ÷ 2 since there
were two SF-12 scales: physical and mental.
We used the power software POWERLIB [54] to pro-
duce a power curve, assuming the treatment and the
control group each has a sample size of 625 participants.
We expect the power to be 0.90 for detecting a 2.5-point




We will calculate summary statistics for the demographic
variables separately for intervention, control and compari-
son groups. Continuous demographic variables will be de-
scribed as mean ± SD or median (25th percentile, 75th
percentile). Categorical demographic variables will be de-
scribed as percentages. We will follow an intent-to-treat
(ITT) approach when performing data analysis.
Primary outcomes
The primary outcomes are the SF-12 scores and clinical
measures including BMI, BP, LDL-C, and Hba1c results
for those who are diabetic. All primary outcomes are
measured at baseline, year 1, year 2, and year 3. For the
clinical measures, yearly values will be calculated by
taking a median of all available values. For each primary
outcome, we will fit linear mixed models to analyze the
repeated measurements using the PROC MIXED pro-
cedure in SAS, Version 9.4. In each model, the responses
are the years 1 to 3 measures. Predictors include the
outcome baseline measure, age, gender, race/ethnicity,
census tract poverty, clinical risk group, treatment, as
well as interactions of treatment-by-baseline, time-by-
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baseline, time-by-treatment, and time-by-treatment-by-
baseline. We will also test estimable trends of time (lin-
ear and quadratic) in the model. We will fit an unstruc-
tured covariance across time and employ necessary
model diagnostic procedures [55]. We will adopt a back-
wards selection strategy to remove insignificant predic-
tors based on the Full Model in Every Cell, followed
with added-in-order tests for all model terms involving
treatment group or time [55].
Longitudinal mediation analysis
In addition to examining the treatment effect on the pri-
mary outcomes, we will also examine whether the treat-
ment effect on the outcomes is mediated through
patient activation (Fig. 1). Given the presence of longitu-
dinal data, we will use an autoregressive mediation
model to evaluate the mediation effect of patient activa-
tion. We will follow the guidelines in Mackinnon for
model building and diagnostics [56]. The time-specific
indirect effects and overall indirect effect of patient acti-
vation will be computed and evaluated for significance.
This will address the question of whether patient activa-
tion mediates the effect of treatment on the primary out-
comes at any time between waves 1 and 4, rather than at
some specific point.
Secondary outcomes
The secondary outcomes are inpatient, outpatient, emer-
gency department, pharmacy, and total expenditures. All
secondary outcomes are also measured at baseline, year
1, year 2, and year 3. We are using the same linear
mixed model analytic approach to analyze these out-
comes. The planned secondary analyses differ from the
primary analyses only in the choice of outcome variable.
We will employ the same model selection and diagnostic
procedures with appropriate attention to the peculiar-
ities of cost distributions (probability masses at zero,
heteroskedasticity, skewness, and kurtosis).
For the comparison group, 1,866 names were sent to
NORC for attempted contact, 674 individuals were
contacted and 404 agreed to participate in the study.
The sociodemographic and diagnostic characteristics of
the comparison group do not differ significantly from
those of the intervention and control groups.
Discussion
The WIN project is a randomized pragmatic clinical trial
designed to promote health and wellness with the goal
of reducing CVD risk among Medicaid enrollees with
mental and/or physical health-related disabilities. This
project has several unique features. First, the project fo-
cuses on individuals who are traditionally not included
in clinical trials – those with co-occurring physical and
mental health conditions and SMI. Second, the study
focuses on increasing participant activation, which has
been shown to result in improved health outcomes,
through a unique combination of strategies: MI, per-
sonal navigators and a flexible wellness account. Third,
the WIN project is unique in its use of a flexible well-
ness account as opposed to traditional financial incen-
tives. Participants have the unique opportunity to make
choices about what will work best for them to meet their
health goals, with the guidance and support of a per-
sonal navigator. The participant-centered approach to
goal setting, the development of strategies to meet those
goals, and the opportunity to choose and pay for goods
and services to implement the strategies is novel; par-
ticularly among this vulnerable population.
Fourth, the WIN project is embedded in a real world
setting. The participating health plans employ the navi-
gators and participate in collaborative monitoring with
the study team on issues of navigator performance and
internal fidelity. The information gained from conduct-
ing the study in a health plan setting will provide valu-
able information about the ultimate sustainability of the
intervention beyond the study. If the health and expend-
iture outcomes are positive, state Medicaid Programs
and their participating health plans will have detailed in-
formation about how to implement such a program
based on the WIN experience.
Fifth, novel data integration strategies are used
throughout the project. The STAR + PLUS Medicaid en-
rollment and claims/encounter data were used for co-
hort identification for the intervention, control, and
comparison groups. Access to the statewide STAR +
PLUS enrollment and claims data made the construction
of a comparison group residing outside of the Harris
Service Area (Houston) possible. Moreover, the linkage
of participant reported outcomes about achievement of
their health goals, electronic health record, and claims/
encounter data provide a comprehensive picture of the
study outcomes for this vulnerable population.
In summary, the novel design of this project and its
participant-centered approaches applied to a rarely
studied population will enhance our knowledge about
strategies for CVD risk reduction among individuals
with co-occurring physical and mental illness.
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